IL-17C as a Driver of Inflammation in Psoriasis

By afschroeder • September 24, 2025

Han G, Armstrong A, Krueger JG, Jacobson A. IL-17C as a Driver of Inflammation in Psoriasis. Adv Ther. 2025 Sep 23. doi: 10.1007/s12325-025-03363-9. Epub ahead of print. PMID: 40986185.

Tags: Amplification+, biologic therapy, brodalumab, Dermatology, IL-17 family, IL-17 receptor A, Publications, Skin inflammation

Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1

Morales A, Korsakova E, Mansooralavi N, Ravikumar A, Rivas G, Soliman P, Rodriguez L, McDaniel T, Lund A, Cooper B, Bhaduri A, Lowry WE. Probing[...]

Improvement of pruritus associated with erythrocytosis in transmasculine patients undergoing gender-affirming therapy with phlebotomy: a report of two patients

Galamgam J, Baroni E, Tsai S, Cheng CE. Improvement of pruritus associated with erythrocytosis in transmasculine patients undergoing gender-affirming therapy with phlebotomy: a report of[...]

Landscape of dermatology education in allopathic medical schools across the United States

Poppens M, McClain W, Collier E, Cheng K, Hogeling M. Landscape of dermatology education in allopathic medical schools across the United States. Dermatol Online J.[...]